Rohit Bose, MD, PhD

Rohit Bose, MD, PhD

Rohit Bose, MD, PhD

Assistant Professor of Anatomy and Urology

Education

Instructor, 2018 - Dept. of Medicine, Genitourinary Service, Memorial Sloan Kettering Cancer Center
Fellowship, 2016 - Advanced Oncology, Memorial Sloan Kettering Cancer Center
Fellowship, Medical Research Track, 2014 - Medical Oncology, Memorial Sloan Kettering Cancer Center
Residency, Medical Research Track, 2010 - Internal Medicine, Weill Cornell Medicine
MD/PhD, 2008 - Medicine & Molecular Genetics, University of Toronto

Biography

I'm a physician-scientist who sees prostate cancer patients, and runs a prostate cancer-focused research lab. Our focus is in understanding hormone-related tumor evolution and dynamics. Understanding how tumors shift their dependencies and identity during therapy is critical to improving patients' clinical care.

Research Interests

September 15, 2023 - August 31, 2028 - Simulating Ancestrally Unbiased Tumor Evolution to Interrogate Drug Resistance , Principal Investigator . Sponsor: NIH Common Fund, Sponsor Award ID: DP2CA290244

July 1, 2022 - June 30, 2026 - Interrogating tumor sub-clonality and shifting dependencies to reduce castration therapy , . Sponsor: American Cancer Society, Sponsor Award ID: RSG-22-021-01-CDP

June 20, 2023 - June 19, 2026 - Profiling and Eliminating Tumor Subclones Destined for Resistance , . Sponsor: DOD Prostate Cancer Program, Sponsor Award ID: P0563731

September 15, 2018 - August 31, 2023 - Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA226348

September 15, 2023 - August 31, 2028 - Simulating Ancestrally Unbiased Tumor Evolution to Interrogate Drug Resistance , Principal Investigator . Sponsor: NIH Common Fund, Sponsor Award ID: DP2CA290244
July 1, 2022 - June 30, 2026 - Interrogating tumor sub-clonality and shifting dependencies to reduce castration therapy , . Sponsor: American Cancer Society, Sponsor Award ID: RSG-22-021-01-CDP
June 20, 2023 - June 19, 2026 - Profiling and Eliminating Tumor Subclones Destined for Resistance , . Sponsor: DOD Prostate Cancer Program, Sponsor Award ID: P0563731
September 15, 2018 - August 31, 2023 - Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA226348

Publications